Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 21Insulin Resistance 5Obesity 4Neoplasms 3Prostatic Neoplasms 2Motor Activity 2Menstruation Disturbances 2Medulloblastoma 2Infertility 2Diabetes Mellitus 2Breast Neoplasms 2Weight Loss 1Vitamin D Deficiency 1Triple Negative Breast Neoplasms 1Toxemia 1Thyroid Neoplasms 1Premature Birth 1Pregnancy Complications 1Prediabetic State 1Pre-Eclampsia 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Non-DM Stage II High-risk Colorectal Cancer 1Neoplasm Metastasis 1Mouth Neoplasms 1Metabolic Syndrome 1Liver Neoplasms 1Infertility, Female 1Hyperinsulinism 1Hyperandrogenism 1

Interventions

lime 1follitropin beta 1follicle stimulating hormone, human, with HCG C-terminal peptide 1Thioctic Acid 1Oocyte Retrieval 1Metformin 1Liraglutide 1Letrozole 1Intravital Microscopy 1Hormone Replacement Therapy 1Desogestrel 1Contraceptives, Oral 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Infertility, Female × Metformin × Clear all
NCT05952882 2023-10-23

Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility

Mỹ Đức Hospital

Phase 3 Unknown
188 enrolled
Other

Infertility, Female, Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡